KR20180022838A - 올티프라즈를 제조하기 위한 방법 - Google Patents

올티프라즈를 제조하기 위한 방법 Download PDF

Info

Publication number
KR20180022838A
KR20180022838A KR1020187002139A KR20187002139A KR20180022838A KR 20180022838 A KR20180022838 A KR 20180022838A KR 1020187002139 A KR1020187002139 A KR 1020187002139A KR 20187002139 A KR20187002139 A KR 20187002139A KR 20180022838 A KR20180022838 A KR 20180022838A
Authority
KR
South Korea
Prior art keywords
hours
minutes
vessel
reaction
toluene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020187002139A
Other languages
English (en)
Korean (ko)
Inventor
보미 피. 프람로즈
Original Assignee
에스티 아이피 홀딩 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스티 아이피 홀딩 아게 filed Critical 에스티 아이피 홀딩 아게
Priority claimed from PCT/IN2016/050197 external-priority patent/WO2016207914A2/en
Publication of KR20180022838A publication Critical patent/KR20180022838A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020187002139A 2015-06-25 2016-06-24 올티프라즈를 제조하기 위한 방법 Ceased KR20180022838A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN1891/DEL/2015 2015-06-25
IN1891DE2015 2015-06-25
US14/823,256 2015-08-11
US14/823,256 US20160376259A1 (en) 2015-06-25 2015-08-11 Methods for Preparing Oltipraz
PCT/IN2016/050197 WO2016207914A2 (en) 2015-06-25 2016-06-24 Methods for preparing oltipraz

Publications (1)

Publication Number Publication Date
KR20180022838A true KR20180022838A (ko) 2018-03-06

Family

ID=57601888

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187002139A Ceased KR20180022838A (ko) 2015-06-25 2016-06-24 올티프라즈를 제조하기 위한 방법

Country Status (7)

Country Link
US (5) US20160376259A1 (cg-RX-API-DMAC7.html)
EP (1) EP3313835A4 (cg-RX-API-DMAC7.html)
JP (1) JP6773693B2 (cg-RX-API-DMAC7.html)
KR (1) KR20180022838A (cg-RX-API-DMAC7.html)
AU (1) AU2016283082B2 (cg-RX-API-DMAC7.html)
CA (1) CA2989228A1 (cg-RX-API-DMAC7.html)
MA (1) MA42264A (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160376259A1 (en) 2015-06-25 2016-12-29 St Ip Holding Ag Methods for Preparing Oltipraz
EP3509642A1 (en) * 2016-09-12 2019-07-17 ST IP Holding AG Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
AU2017322544B2 (en) * 2016-09-12 2022-06-02 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL171985C (nl) * 1976-02-10 1983-06-16 Rhone Poulenc Ind Werkwijze voor het bereiden van preparaten met werking tegen schistosomiasis, de aldus verkregen gevormde preparaten en werkwijze voor het bereiden van 1,2-dithioolverbindingen.
AU6462500A (en) * 1999-07-29 2001-02-19 Patrick T. Prendergast Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
AU780161B2 (en) 2000-04-07 2005-03-03 Sang Geon Kim Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
ATE540586T1 (de) * 2000-11-20 2012-01-15 Applied Food Sciences Inc Verfahren zur erhöhung des gehalts an zuträglichen verbindungen nach der verarbeitung in getränken, in denen diese verbindungen natürlich vorkommen
KR100491318B1 (ko) * 2002-11-26 2005-05-24 씨제이 주식회사 올티프라즈(Oltipraz) 제조방법
KR100629771B1 (ko) 2004-01-27 2006-09-28 씨제이 주식회사 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법
US20160376259A1 (en) 2015-06-25 2016-12-29 St Ip Holding Ag Methods for Preparing Oltipraz

Also Published As

Publication number Publication date
US10968207B2 (en) 2021-04-06
EP3313835A2 (en) 2018-05-02
US20160376259A1 (en) 2016-12-29
EP3313835A4 (en) 2019-01-09
US20210206752A1 (en) 2021-07-08
MA42264A (fr) 2018-05-02
CA2989228A1 (en) 2016-12-29
JP2018520134A (ja) 2018-07-26
US20200247791A1 (en) 2020-08-06
AU2016283082A1 (en) 2018-01-18
AU2016283082B2 (en) 2020-11-26
US20190084971A1 (en) 2019-03-21
US20200172522A1 (en) 2020-06-04
JP6773693B2 (ja) 2020-10-21

Similar Documents

Publication Publication Date Title
CA2788459C (en) Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
WO2016207914A2 (en) Methods for preparing oltipraz
US10968207B2 (en) Methods for preparing oltipraz
TWI462913B (zh) 製備抗壞血酸衍生物之方法
IL299857A (en) 4-furanamides and a method for their production
CN115417753B (zh) 一种美利曲辛及其中间体的合成方法
CN111718264A (zh) 一种2-甲基-6-硝基苯甲酸与3-硝基-2-甲基苯甲酸联产的方法
JP7824778B2 (ja) 脱水縮合をともなう環化反応による環化生成物の製造方法、および1,3,4-置換-ピラゾール-5-カルボン酸エステル類の製造方法
US4284797A (en) Process for separating mixtures of 3- and 4-nitrophthalic acid
US3349095A (en) 1-(5'-nitrofuryl)-1, 3-diketopropane derivatives and their preparation
US3180891A (en) Method for preparing thioformanilide
Liese et al. A convenient general access to methyl 2-chloro-2-cyclopropylidenacetates, reactive Michael acceptors and cycloaddends
CN110650735A (zh) 通过钯-催化的分子内链烯基化的4,5-螺环的高度非对映选择性结构
US6548692B1 (en) Method for preparing 1,2-dibromo-2,4-dicyanobutane
JP7818013B2 (ja) 4-オキソテトラヒドロフラン-2-カルボン酸アルキルの調製方法
Vanderhaeghe Phenoxazines. I. Ring-Substituted Derivatives
CN110669031B (zh) 天然产物异猴头菌酮j的全合成方法
AU2021323385B2 (en) Process for producing dimethyl 2,3,5,6- tetrachloro-1,4-benzenedicarboxylate
US3652643A (en) Methyl 3 3-dichloro-1-lower alkoxy-2-oxo cyclopentane carboxylate
RU2495033C2 (ru) СПОСОБ ПОЛУЧЕНИЯ 2-(1-АДАМАНТИЛКАРБОНИЛ)-1,2-ДИГИДРОНАФТО[2,1-b]ФУРАНОВ
RU2814175C2 (ru) Способы получения 1,3-бензодиоксольных гетероциклических соединений
SU1721051A1 (ru) Способ получени 2-галоидпроизводных фурана
JPH0557249B2 (cg-RX-API-DMAC7.html)
SU585164A1 (ru) Способ получени трет-алкилхинолил-8-карбонатов
RU2664801C2 (ru) Способ получения фенотиазина

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20180123

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210623

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230816

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20240220

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20230816

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

E601 Decision to refuse application
E801 Decision on dismissal of amendment
PE0601 Decision on rejection of patent

Patent event date: 20240823

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

PE0801 Dismissal of amendment

Patent event code: PE08012E01D

Comment text: Decision on Dismissal of Amendment

Patent event date: 20240823